What Investors Don't Know: Communist China Could Profit Billions From The World "Going Green."

From Investing Trends | Ad

Who controls 80% of the works lithium supply (the most important metal for building EV batteries)? China! And if you're outraged by that fact, then you'll love hearing how this western company is fighting back…

See How This Anti-China Lithium Play Could Explode

NBIX Insider Trading (Neurocrine Biosciences)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $44,203,410.82

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$101.26

▼ -0.58 (-0.57%)

As of 10/27/2021 05:00 PM ET

Days: 30 | 90 | 365

This unknown stock signed an Exclusive Counter-Drone Technology License Agreement

From Emerging Markets Consulting | Ad

Add in the Non-Lethal Low Energy Cartridge as a potential alternative to Police using handguns

And you have a potentially explosive company.

Click here to learn more

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/7/2021	Dimitri E Grigoriadis	Insider	Sell	8,000	$104.81	$838,480.00
10/7/2021	Gary A. Lyons	Director	Sell	5,000	$105.06	$525,300.00
10/4/2021	Julie Cooke	Insider	Sell	987	$101.73	$100,407.51
8/16/2021	Eric Benevich	Insider	Sell	5,628	$89.62	$504,381.36
7/27/2021	Malcolm Lloyd-Smith	Insider	Sell	16,709	$93.80	$1,567,304.20	15,801
6/10/2021	Gary A. Lyons	Director	Sell	10,000	$100.27	$1,002,700.00
2/10/2021	Malcolm Lloyd-Smith	Insider	Sell	1,700	$119.96	$203,932.00	33,610
2/8/2021	Eiry Roberts	Insider	Sell	2,363	$116.78	$275,951.14	17,231
2/8/2021	Kevin Charles Gorman	CEO	Sell	10,466	$116.75	$1,221,905.50	443,249
2/8/2021	Matt Abernethy	CFO	Sell	2,910	$116.82	$339,946.20	13,043
2/5/2021	Kevin Charles Gorman	CEO	Sell	2,422	$114.16	$276,495.52	443,249
2/5/2021	Malcolm Lloyd-Smith	Insider	Sell	865	$114.15	$98,739.75	29,675
1/26/2021	Malcolm Lloyd-Smith	Insider	Sell	1,100	$119.97	$131,967.00	33,013
1/25/2021	Gary A. Lyons	Director	Sell	1,600	$120.03	$192,048.00
1/8/2021	Eiry Roberts	Insider	Sell	2,632	$111.06	$292,309.92	15,845
1/8/2021	Kevin Charles Gorman	CEO	Sell	308,250	$110.22	$33,975,315.00	584,520
12/1/2020	Matt Abernethy	CFO	Sell	1,645	$94.66	$155,715.70	11,494
11/12/2020	Eric Benevich	Insider	Sell	2,257	$90.71	$204,732.47	17,405
11/12/2020	Kevin Charles Gorman	CEO	Sell	3,390	$90.78	$307,744.20	441,071
11/2/2020	Eric Benevich	Insider	Sell	20,595	$96.53	$1,988,035.35	35,969
10/2/2020	Julie Cooke	Insider	Sell	987	$95.26	$94,021.62	9,549
8/5/2020	Eiry Roberts	Insider	Sell	2,257	$118.84	$268,221.88	11,446
8/5/2020	Kevin Charles Gorman	CEO	Sell	3,390	$118.91	$403,104.90	438,021
7/9/2020	Darin Lippoldt	Insider	Sell	1,657	$136.02	$225,385.14	27,678
6/23/2020	Eiry Roberts	Insider	Sell	5,000	$130.00	$650,000.00	14,416
5/18/2020	Darin Lippoldt	Insider	Sell	5,000	$120.00	$600,000.00	31,021
5/12/2020	Haig P Bozigian	Insider	Sell	61,555	$114.94	$7,075,131.70	157,727
5/7/2020	Dimitri E Grigoriadis	Insider	Sell	8,682	$105.44	$915,430.08	104,741
5/7/2020	Matt Abernethy	CFO	Sell	15,000	$110.21	$1,653,150.00	20,953
4/28/2020	Matt Abernethy	CFO	Sell	1,741	$102.49	$178,435.09	5,953
4/28/2020	Stephen A Sherwin	Director	Sell	17,687	$99.39	$1,757,910.93	29,861
4/24/2020	Eiry Roberts	Insider	Sell	1,934	$99.47	$192,374.98
4/24/2020	Kevin Charles Gorman	CEO	Sell	2,906	$99.45	$289,001.70	434,971
4/15/2020	Eric Benevich	Insider	Sell	8,632	$94.65	$817,018.80
2/10/2020	Malcolm Lloyd-Smith	Insider	Sell	28,969	$104.56	$3,028,998.64	23,200
2/7/2020	Eiry Roberts	Insider	Sell	1,623	$103.31	$167,672.13	7,452
2/7/2020	Kevin Charles Gorman	CEO	Sell	3,248	$103.35	$335,680.80	432,357
2/7/2020	Matt Abernethy	CFO	Sell	2,030	$103.35	$209,800.50	5,701
2/5/2020	Kevin Charles Gorman	CEO	Sell	5,449	$103.09	$561,737.41	423,351
2/5/2020	Kyle Gano	Insider	Sell	3,690	$103.05	$380,254.50
1/8/2020	Eiry Roberts	Insider	Sell	2,632	$111.11	$292,441.52
12/2/2019	Matt Abernethy	CFO	Sell	1,645	$116.33	$191,362.85
11/18/2019	Dimitri E Grigoriadis	Insider	Sell	5,000	$115.98	$579,900.00	113,408
11/8/2019	Darin Lippoldt	Insider	Sell	10,000	$110.01	$1,100,100.00	26,728
11/8/2019	Gary A. Lyons	Director	Sell	5,000	$110.00	$550,000.00	225,697
11/1/2019	Dimitri E Grigoriadis	Insider	Sell	10,188	$100.34	$1,022,263.92	118,596
11/1/2019	Gary A. Lyons	Director	Sell	5,000	$100.22	$501,100.00	230,697
10/14/2019	Malcolm Lloyd-Smith	Insider	Sell	9,956	$90.85	$904,502.60
10/2/2019	Julie Cooke	Insider	Sell	987	$88.56	$87,408.72
9/3/2019	Darin Lippoldt	Insider	Sell	6,736	$100.00	$673,600.00
8/27/2019	Darin Lippoldt	Insider	Sell	3,264	$100.05	$326,563.20	21,625
8/23/2019	Darin Lippoldt	Insider	Sell	1,664	$100.09	$166,549.76	21,625
8/8/2019	Kevin Charles Gorman	CEO	Sell	80,000	$95.31	$7,624,800.00	468,508
8/6/2019	Kevin Charles Gorman	CEO	Sell	50,911	$95.15	$4,844,181.65	468,508
7/30/2019	Darin Lippoldt	Insider	Sell	15,831	$92.13	$1,458,510.03	160,732
7/30/2019	Gary A. Lyons	Director	Sell	10,000	$92.07	$920,700.00	235,697
7/15/2019	Eric Benevich	Insider	Sell	5,835	$87.44	$510,212.40	14,910
7/11/2019	Haig P Bozigian	Insider	Sell	7,220	$87.63	$632,688.60	149,096
6/18/2019	Haig P Bozigian	Insider	Sell	2,100	$87.82	$184,422.00	144,076
6/13/2019	Haig P Bozigian	Insider	Sell	17,268	$82.62	$1,426,682.16	157,812
6/3/2019	Haig P Bozigian	Insider	Sell	3,435	$85.51	$293,726.85	145,411
5/31/2019	Haig P Bozigian	Insider	Sell	19,297	$85.02	$1,640,630.94	161,273
5/24/2019	Haig P Bozigian	Insider	Sell	17,486	$80.03	$1,399,404.58	159,462
5/22/2019	Haig P Bozigian	Insider	Sell	1,300	$80.03	$104,039.00	143,276
5/16/2019	Haig P Bozigian	Insider	Sell	66,667	$80.13	$5,342,026.71	164,415
5/13/2019	Haig P. Bozigian	Insider	Sell	34,547	$75.51	$2,608,643.97
2/5/2019	Kevin Charles Gorman	CEO	Sell	7,614	$88.16	$671,250.24	408,082
2/5/2019	Kyle Gano	Insider	Sell	3,809	$88.12	$335,649.08	17,595
1/8/2019	Eiry Roberts	Insider	Sell	1,857	$84.09	$156,155.13	3,143
12/3/2018	Matt Abernethy	CFO	Sell	1,178	$90.00	$106,020.00	1,947
11/26/2018	Richard F Pops	Director	Sell	4,124	$91.37	$376,809.88	29,512
11/12/2018	Richard F Pops	Director	Sell	4,123	$103.30	$425,905.90	33,636
11/7/2018	Malcolm Lloyd-Smith	Insider	Sell	9,000	$110.01	$990,090.00	21,018
11/2/2018	Gary A. Lyons	Director	Sell	15,000	$114.41	$1,716,150.00
10/29/2018	Richard F Pops	Director	Sell	5,500	$107.13	$589,215.00	37,759

Insider Buying at Neurocrine Biosciences?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Neurocrine Biosciences and related companies.

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

95.99% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/27/2021	State of New Jersey Common Pension Fund D	58,900	$5.65M	0.0%	+2.4%	0.062%
10/27/2021	State of Michigan Retirement System	23,700	$2.27M	0.0%	-0.4%	0.025%
10/27/2021	Phoenix Holdings Ltd.	16,281	$1.53M	0.0%	+3.2%	0.017%
10/26/2021	Fisher Asset Management LLC	69,194	$6.64M	0.0%	+12.2%	0.073%
10/25/2021	Highland Capital Management LLC	8,901	$0.85M	0.1%	-8.2%	0.009%
10/25/2021	Sumitomo Mitsui Trust Holdings Inc.	264,459	$25.36M	0.0%	-2.1%	0.280%
10/22/2021	Beck Bode LLC	62,740	$6.02M	1.7%	N/A	0.066%
10/22/2021	DekaBank Deutsche Girozentrale	35,085	$3.31M	0.0%	-2.0%	0.037%
10/22/2021	YorkBridge Wealth Partners LLC	3,731	$0.36M	0.1%	+22.2%	0.004%
10/21/2021	Park Avenue Securities LLC	5,777	$0.55M	0.0%	+10.8%	0.006%
10/19/2021	Bristlecone Advisors LLC	3,770	$0.36M	0.0%	+13.3%	0.004%
10/19/2021	Oregon Public Employees Retirement Fund	31,838	$3.05M	0.0%	-1.3%	0.034%
10/19/2021	Assenagon Asset Management S.A.	11,191	$1.07M	0.0%	-77.2%	0.012%
10/18/2021	Exchange Traded Concepts LLC	6,150	$0.59M	0.0%	+1,038.9%	0.007%
10/18/2021	Nisa Investment Advisors LLC	4,086	$0.39M	0.0%	-23.2%	0.004%
10/15/2021	Pacer Advisors Inc.	9,666	$0.93M	0.0%	-2.4%	0.010%
10/15/2021	NEXT Financial Group Inc	3,627	$0.35M	0.0%	+24.5%	0.004%
10/15/2021	DNB Asset Management AS	118,279	$11.34M	0.1%	-14.4%	0.125%
10/14/2021	Unigestion Holding SA	9,747	$0.92M	0.0%	+10.1%	0.010%
10/13/2021	Scout Investments Inc.	254,714	$24.43M	0.4%	-1.5%	0.269%
10/13/2021	Harbour Capital Advisors LLC	12,871	$1.23M	0.3%	+11.1%	0.014%
10/13/2021	Private Capital Group LLC	603	$58K	0.0%	+98.4%	0.001%
10/13/2021	IFM Investors Pty Ltd	14,714	$1.41M	0.0%	+5.3%	0.016%
10/12/2021	Louisiana State Employees Retirement System	24,100	$2.31M	0.1%	-1.6%	0.025%
10/7/2021	State of Alaska Department of Revenue	14,526	$1.39M	0.0%	-1.1%	0.015%
10/4/2021	Red Spruce Capital LLC	11,746	$1.13M	0.7%	-0.9%	0.012%
9/24/2021	Thrivent Financial for Lutherans	25,099	$2.44M	0.0%	+0.5%	0.027%
9/17/2021	Virtu Financial LLC	6,410	$0.62M	0.1%	+42.0%	0.007%
9/13/2021	Bank of America Corp DE	580,287	$56.47M	0.0%	-20.6%	0.614%
9/3/2021	Parametric Portfolio Associates LLC	222,416	$21.65M	0.0%	+22.5%	0.235%
8/30/2021	B. Metzler seel. Sohn & Co. Holding AG	4,393	$0.43M	0.0%	+41.4%	0.005%
8/26/2021	Comerica Bank	144,730	$12.96M	0.1%	+26.0%	0.153%
8/19/2021	Thrivent Financial for Lutherans	25,099	$2.44M	0.0%	+0.5%	0.027%
8/17/2021	Walleye Capital LLC	7,987	$0.78M	0.0%	N/A	0.008%
8/17/2021	Weiss Multi Strategy Advisers LLC	32,224	$3.14M	0.1%	+3.7%	0.034%
8/17/2021	Woodline Partners LP	385,054	$37.47M	0.7%	N/A	0.407%
8/17/2021	Zeke Capital Advisors LLC	3,466	$0.34M	0.0%	+16.4%	0.004%
8/17/2021	Perceptive Advisors LLC	811,832	$79.01M	1.0%	-13.8%	0.859%
8/17/2021	Capital Impact Advisors LLC	24,496	$2.38M	0.8%	+66.2%	0.026%
8/17/2021	Metropolitan Life Insurance Co NY	22,387	$2.18M	0.0%	+97,234.8%	0.024%
8/17/2021	MetLife Investment Management LLC	47,242	$4.60M	0.0%	-2.6%	0.050%
8/17/2021	PFM Health Sciences LP	1,116,004	$108.61M	3.4%	+5.7%	1.180%
8/17/2021	Price T Rowe Associates Inc. MD	5,029,259	$489.45M	0.0%	-12.9%	5.319%
8/17/2021	Prudential Financial Inc.	23,323	$2.27M	0.0%	-39.5%	0.025%
8/17/2021	Paloma Partners Management Co	2,468	$0.24M	0.0%	N/A	0.003%
8/17/2021	ArrowMark Colorado Holdings LLC	597,599	$58.16M	0.4%	-5.0%	0.632%
8/17/2021	Boothbay Fund Management LLC	3,432	$0.33M	0.0%	N/A	0.004%
8/16/2021	Squarepoint Ops LLC	19,240	$1.87M	0.0%	+575.8%	0.020%
8/16/2021	AQR Capital Management LLC	40,511	$3.91M	0.0%	-3.8%	0.043%
8/16/2021	Bank of America Corp DE	580,287	$56.47M	0.0%	-20.6%	0.614%
8/16/2021	Amalgamated Bank	74,303	$7.23M	0.1%	+329.1%	0.079%
8/16/2021	FORA Capital LLC	2,863	$0.28M	0.1%	-8.3%	0.003%
8/16/2021	Cubist Systematic Strategies LLC	22,116	$2.15M	0.0%	-13.6%	0.023%
8/16/2021	Glenmede Trust Co. NA	35,333	$3.44M	0.0%	-1.5%	0.037%
8/16/2021	California State Teachers Retirement System	167,794	$16.33M	0.0%	-4.2%	0.177%
8/16/2021	Perceptive Advisors LLC	811,832	$79.01M	1.0%	-13.8%	0.859%
8/16/2021	Capital International Inc. CA	337,467	$32.84M	0.3%	-5.6%	0.357%
8/16/2021	First Trust Advisors LP	647,555	$63.02M	0.1%	-1.0%	0.685%
8/16/2021	Public Employees Retirement System of Ohio	53,391	$5.20M	0.0%	+8.0%	0.056%
8/16/2021	Capital International Investors	1,116,163	$108.63M	0.0%	-29.0%	1.181%
8/16/2021	Tudor Investment Corp Et Al	24,060	$2.34M	0.0%	N/A	0.025%
8/16/2021	Amundi	121,786	$11.85M	0.0%	N/A	0.129%
8/16/2021	Schonfeld Strategic Advisors LLC	20,300	$1.98M	0.0%	N/A	0.021%
8/16/2021	Echo Street Capital Management LLC	8,724	$0.85M	0.0%	N/A	0.009%
8/16/2021	Charles Schwab Investment Management Inc.	479,649	$46.68M	0.0%	+2.7%	0.507%
8/16/2021	Andra AP fonden	55,800	$5.43M	0.1%	+402.7%	0.059%
8/16/2021	Nuveen Asset Management LLC	366,260	$35.64M	0.0%	-18.7%	0.387%
8/16/2021	Cinctive Capital Management LP	77,039	$7.50M	0.4%	+57.9%	0.081%
8/16/2021	Federated Hermes Inc.	63,545	$6.18M	0.0%	-57.6%	0.067%
8/16/2021	MML Investors Services LLC	8,594	$0.84M	0.0%	+28.7%	0.009%
8/16/2021	Allianz Asset Management GmbH	162,577	$15.82M	0.0%	+107.2%	0.172%
8/13/2021	Renaissance Technologies LLC	1,242,723	$120.94M	0.2%	-11.1%	1.314%
8/13/2021	Northern Trust Corp	895,859	$87.19M	0.0%	-6.8%	0.948%
8/13/2021	Caisse DE Depot ET Placement DU Quebec	15,269	$1.49M	0.0%	N/A	0.016%
8/13/2021	Natixis	7,424	$0.72M	0.0%	N/A	0.008%
8/13/2021	APG Asset Management N.V.	9,110	$0.75M	0.0%	-92.3%	0.010%
8/13/2021	Neuberger Berman Group LLC	3,141	$0.31M	0.0%	+6.5%	0.003%
8/13/2021	QS Investors LLC	2,058	$0.20M	0.0%	-12.7%	0.002%
8/13/2021	California Public Employees Retirement System	211,026	$20.54M	0.0%	-5.3%	0.223%
8/13/2021	LPL Financial LLC	14,163	$1.38M	0.0%	+117.6%	0.015%
8/13/2021	Stifel Financial Corp	36,017	$3.51M	0.0%	+13.0%	0.038%
8/13/2021	Bridgewater Associates LP	5,934	$0.58M	0.0%	N/A	0.006%
8/13/2021	Ensign Peak Advisors Inc	109,279	$10.64M	0.0%	+124.5%	0.116%
8/13/2021	Fort L.P.	6,014	$0.59M	0.2%	-36.6%	0.006%
8/13/2021	Toronto Dominion Bank	13,436	$1.31M	0.0%	+12.0%	0.014%
8/13/2021	DSM Capital Partners LLC	1,535,484	$149.43M	1.4%	+13.9%	1.624%
8/13/2021	Qube Research & Technologies Ltd	45,085	$4.39M	0.1%	N/A	0.048%
8/13/2021	AXA S.A.	6,200	$0.60M	0.0%	+198.8%	0.007%
8/13/2021	Northwestern Mutual Investment Management Company LLC	15,746	$1.53M	0.0%	+0.9%	0.017%
8/13/2021	Geode Capital Management LLC	1,203,134	$116.92M	0.0%	+2.0%	1.273%
8/13/2021	Vanguard Group Inc.	8,984,621	$874.38M	0.0%	+1.8%	9.503%
8/13/2021	Massachusetts Financial Services Co. MA	143,328	$13.95M	0.0%	-0.3%	0.152%
8/13/2021	Vident Investment Advisory LLC	4,953	$0.48M	0.0%	+6.0%	0.005%
8/13/2021	Rhenman & Partners Asset Management AB	105,000	$10.22M	0.7%	-32.3%	0.111%
8/13/2021	ProShare Advisors LLC	27,548	$2.68M	0.0%	+25.3%	0.029%
8/12/2021	Trexquant Investment LP	8,294	$0.81M	0.1%	N/A	0.009%
8/12/2021	Profund Advisors LLC	21,143	$2.06M	0.1%	-2.0%	0.022%
8/12/2021	Shelton Capital Management	5,208	$0.51M	0.0%	N/A	0.006%
8/12/2021	AlphaCrest Capital Management LLC	24,788	$2.41M	0.1%	+114.9%	0.026%
8/12/2021	Healthcare of Ontario Pension Plan Trust Fund	258	$25K	0.0%	-74.3%	0.000%

Data available starting January 2016

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Today's Range

Now: $101.26

$100.51

$102.37

50 Day Range

MA: $95.98

$86.18

$104.86

52 Week Range

Now: $101.26

$84.77

$120.27

Volume

338,410 shs

Average Volume

850,170 shs

Market Capitalization

$9.57 billion

P/E Ratio

27.22

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Haig P Bozigian (Insider)
Dimitri E Grigoriadis (Insider)
Eric Benevich (Insider)
Malcolm Lloyd-Smith (Insider)
Darin Lippoldt (Insider)
Stephen A Sherwin (Director)
Matt Abernethy (CFO)
Eiry Roberts (Insider)
Julie Cooke (Insider)
Kyle Gano (Insider)
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
Sumitomo Mitsui Trust Holdings Inc. — 0.28%
Scout Investments Inc. — 0.27%
DNB Asset Management AS — 0.13%
Fisher Asset Management LLC — 0.07%
Beck Bode LLC — 0.07%
State of New Jersey Common Pension Fund D — 0.06%
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
DNB Asset Management AS
Sumitomo Mitsui Trust Holdings Inc.
Scout Investments Inc.
Nisa Investment Advisors LLC
Highland Capital Management LLC
DekaBank Deutsche Girozentrale
Oregon Public Employees Retirement Fund
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Haig P Bozigian (Insider)
Dimitri E Grigoriadis (Insider)
Eric Benevich (Insider)
Malcolm Lloyd-Smith (Insider)
Darin Lippoldt (Insider)
Stephen A Sherwin (Director)
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
Beck Bode LLC
Fisher Asset Management LLC
Exchange Traded Concepts LLC
State of New Jersey Common Pension Fund D
Harbour Capital Advisors LLC
Unigestion Holding SA
IFM Investors Pty Ltd
NEXT Financial Group Inc